Current Cancer Therapy Reviews

Editor-in-Chief:

Kurt S. Zaenker
Institute of Immunology and Experimental Oncology
Witten/Herdecke University
Stockumerstraße 10, 58448 Witten
Germany

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:13   Issue: 1
Pp: 1-1
John F. Deeken
DOI: 10.2174/157339471301170829115741



Preface free to download

Volume:13   Issue: 1
Pp: 2-2
Kurt S. Zaenker
DOI: 10.2174/157339471301170829120019



Erlotinib: A Targeted Anticancer Drug

Volume:13   Issue: 1
Pp: 3-16
Parijat Pandey and Harish Dureja*
DOI: 10.2174/1573394713666170522181615



Cancer and Treatment Modalities

Volume:13   Issue: 1
Pp: 17-27
Elham Hosseinzadeh, Nooshin Banaee* and Hassan Ali Nedaie
DOI: 10.2174/1573394713666170531081818



Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein

Volume:13   Issue: 1
Pp: 28-42
Ravinesh Mishra*, Swati Sareen, Bhartendu Sharma, Shubham Goyal, Gurpreet Kaur, Sweta Bhardwaj, Anees A. Siddiqui, Asif Husain, Rajeev K. Singla, Mohd Rashid, Deepak Kumar, Bhawana Sati, Nishtha Shalmali and Rajiv Kumar
DOI: 10.2174/1573394713666170524122904



Targeted Nanosystems for Cancer Therapy

Volume:13   Issue: 1
Pp: 63-73
Ruhee Jain, Tahseen Khan, Sourabh Jain, Ashutosh Pal Jain and Aakanchha Jain*
DOI: 10.2174/1573394713666170622104347